Protein Complementation of Plant-based Diets.

NCT ID: NCT07151625

Last Updated: 2025-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-10-01

Study Completion Date

2029-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Amino acids are the building blocks of proteins which are needed by the body for growth, and bodily functions. If even one amino acid is in short supply, this will negatively affect growth and various functions in the body. Animal foods like meat, fish and chicken contain all the amino acids needed by the body in the correct proportion. These foods are considered high quality protein foods. However plant proteins like lentils, wheat, rice are low in at least one amino acid. This means that plant proteins are considered low quality proteins.

Data from the investigators lab and others show that when eating plant foods, combining grains and legumes like rice and beans, peanut butter and bread, (protein complementation) will provide a complete protein which contains all the amino acids needed by the body. However, some maintain that it is not necessary to combine foods like grains and legumes in the same meal as long as all the amino acids are consumed within a 24h period. This has never been tested.

The goal of this study is to compare the effects non-complementation to protein complementization on whole body protein metabolism in young and older adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Complementation of plant proteins with complementary amino acid profile (cereal grain + legume) in each meal can improve the protein quality of plant based diets. However, some maintain that if a variety of plant foods are consumed throughout the day, all essential amino acids are provided and protein complementation at each meal is unnecessary. This assumption has NEVER been tested, yet it forms the basis of current expert recommendations for vegetarian diets. Evidence from the investigators lab and others demonstrate that there is no storage pool of amino acids in the body; when one amino acid is deficient in the diet for protein synthesis, all others are in relative excess and are oxidized resulting in poor growth and lower rates of protein synthesis. Therefore, current recommendations for plant based diet consumption could be misleading.

Skeletal muscle plays an important role in the adaptations of body proteins to nutritional changes and during stress. Therefore, knowledge of skeletal muscle response to changes in dietary protein intake from animal to plant based protein is an important prerequisite to understand the body's capacity, especially in the elderly, to adapt to alterations in dietary protein quality from animal to plant based, whether in complementation or non-complementation fashion. The contribution of skeletal muscle to protein breakdown is calculated by measuring urinary 3-methylhistidine. This amino acid is produced in muscle from post-translational modification of histidine and released from actin and myosin. It is not reutilized for protein synthesis but is excreted in the urine. Therefore, the urinary output of 3-methylhistidine is a quantitative index of daily muscle protein breakdown.

Objectives:

1. To assess whole-body protein metabolism (WBPM) (protein synthesis, protein breakdown and protein balance) using a single dose \[15N\]glycine and measuring cumulative excretion of \[15N\]urea in urine in human adult consuming a PB diet provided in a complementary or non-complementary fashion in males and females 18 -39, 60-69 and 70-79 years and
2. To assess the contribution of skeletal muscle to protein breakdown by measuring urinary 3-methyhistidine.

Hypothesis:

Protein synthesis and balance will be lower, but breakdown will be higher in the non-complementation PB diets compared to omnivorous diet (control) and lacto-vegetarian diet.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Each Participant Will be Studied Over 5 Dietary Periods, Each Over 9d

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

protein synthesis, breakdown and balance assessed after exposure to 5 diets consumed over 9d

Group Type OTHER

Diet, whole food provided to participants over 5 x 9 day period

Intervention Type OTHER

5 diets provided to participants over 9 days each and whole body protein synthesis, protein breakdown and protein balance assessed after each period.

Diet

Intervention Type OTHER

5 different diet types

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Diet, whole food provided to participants over 5 x 9 day period

5 diets provided to participants over 9 days each and whole body protein synthesis, protein breakdown and protein balance assessed after each period.

Intervention Type OTHER

Diet

5 different diet types

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\) Young Adults:
* Adults, age 18 - 39 yrs, Healthy with no known clinical condition which would affect protein or AA metabolism, ex. Diabetes, Stable Body Weight (no more than 5 lb weight loss or gain in the past 3 months)
* Not on any medications that could affect protein or amino acid metabolism e.g. steroids.
* Fasting blood glucose, hemoglobin A1C (HbA1c), urea and creatinine within normal ranges for age.

2\) Older Adults:
* Adults, aged 60-69 and 70-79 years, Healthy with no known clinical condition which would affect protein or AA metabolism, ex. Diabetes, Stable Body Weight (no more than 5 lb weight loss or gain in the past 3 months)
* Not on any medications that could affect protein or amino acid metabolism e.g. steroids,
* Fasting blood glucose, hemoglobin A1C (HbA1c), urea and creatinine within normal ranges for age.

Exclusion Criteria

* Unwillingness to participate or unable to tolerate the diet
* Recent history of weight loss within the last 3 months or on a weight reducing diet Inability to tolerate study diets (ex. Allergy to ingredients).
* Significant caffeine consumption (\>2 cups per day)
* Significant alcohol consumption (\>1 drink per day i.e. 1 beer or ½ glass of wine).
* Fasting blood glucose, hemoglobin A1C (HbA1c), urea and creatinine outside of normal ranges for age.
* On medications known to affect protein and AA metabolism, renal failure, liver disease, unable to ambulate independently.
Minimum Eligible Age

18 Years

Maximum Eligible Age

79 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Hospital for Sick Children

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Glenda Courtney-Martin

Senior Associate Scientist- Translational Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Glenda Courtney-Martin, PhD, RD

Role: PRINCIPAL_INVESTIGATOR

Research Institute, The Hospital for Sick Children

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Hospital for Sick Children

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Mahroukh Rafii, BSc

Role: CONTACT

416-813-7454

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Glenda Courtney-Martin, PhD, RD

Role: primary

4168135744

Mahroukh Rafii, BSc

Role: backup

416-813-7454

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PJT-198014

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

3667

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.